SEC Form 4 · accession 0001628280-26-041637
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia Madsen
Officer — Sr. VP and GM, Life Sciences
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001757898
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jun 4, 2026 | F | 195 | $212.24 | D | 12,257 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.
- F2As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.